Genetic Counseling for Breast Cancer Risk
(PCS IV Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist mothers with a genetic risk for breast cancer in discussing the condition with their children. It provides education and support to facilitate more informed and easier conversations. Participants will be divided into two groups: one receiving enhanced care with additional education and counseling, including genetic counseling, and the other receiving usual care. This trial suits mothers or primary caregivers undergoing genetic testing for hereditary breast cancer who can communicate comfortably in English. As an unphased trial, it offers a unique opportunity to access valuable support and resources for navigating conversations about genetic risk.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this genetic counseling and education is safe?
Research has shown that educational programs about cancer risk are generally safe and manageable. For example, one study found that women who learned about cancer risk gained a better understanding of the disease, with no reports of harmful effects from the education itself.
Similarly, studies on genetic counseling, a form of guidance and information sharing, have shown it to be safe for participants. It helps people understand their risk without causing physical harm. Participants often learn more about hereditary cancer risks, such as BRCA mutations, without experiencing negative side effects.
Both education and counseling aim to increase awareness and help people make informed decisions. These activities focus on providing knowledge and emotional support, rather than medical treatments, making them safe options for those involved.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different educational approaches can impact breast cancer risk awareness and decision-making. Unlike standard care, which may involve general risk assessments, this trial investigates the added benefits of combining education with personalized genetic counseling. This method aims to empower individuals with tailored insights into their genetic risk, potentially leading to more informed and proactive healthcare decisions.
What evidence suggests that this trial's educational and counseling interventions could be effective for hereditary breast cancer risk management?
Research has shown that educational programs, one approach in this trial, can greatly enhance women's understanding and confidence regarding breast cancer. One study found that these programs improved women's skills and encouraged them to seek medical help. Additionally, increased knowledge about breast cancer can help reduce related anxiety and depression.
In this trial, some participants will receive education combined with counseling. Studies have found that genetic counseling improves understanding of inherited breast cancer, aiding individuals in making informed health decisions, especially if they have a genetic risk. Counseling also plays a crucial role in creating personalized health plans for those at higher risk.36789Are You a Good Fit for This Trial?
This trial is for mothers or primary caregivers to adolescents and young adults aged 13-24 who are undergoing genetic testing for hereditary breast cancer. Participants must be able to speak and read English well.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Mothers receive genetic counseling and support to improve communication about hereditary breast cancer
Follow-up
Participants are monitored for communication effectiveness and psychological well-being
What Are the Treatments Tested in This Trial?
Interventions
- Education
- Education and counseling
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor